Jiang V W, Gibson R E, Rzeszotarski W J, Eckelman W C, Reba R C
J Nucl Med. 1978 Aug;19(8):918-24.
Four new beta-adrenoceptor blocking agents carrying tyramine as the amino moiety were synthesized and the distribution of their I-125-tagged derivatives evaluated in rats. This distribution was compared with the distribution of various agonists and antagonists labeled with H-3 and C-14, and with the in vitro binding affinity of the new derivatives. A radioiodinated derivative of a cardioselective blocker, alprenolol, showed poor blood clearance and no cardiac selectivity. A derivative of another cardioselective blocker, practolol, showed a promising heart-to-blood ratio (ca. 19) and cardioselectivity with a heart-to-lung ratio of ca. 2. Two additional practolol analogs showed no improvement over the practolol derivative; because of the increased lipophilicity of these derivatives, blood clearance and cardioselectivity were diminished. An inverse correlation is suggested between the dissociation constant for the beta adrenoceptor in the lung and the heart-to-blood and heart-to-lung values. We conclude that polarity plays an important role in the blood clearance and cardioselectivity of these beta-adrenoceptor derivatives.
合成了四种以酪胺为氨基部分的新型β-肾上腺素能受体阻滞剂,并在大鼠体内评估了它们的碘-125标记衍生物的分布。将这种分布与用氢-3和碳-14标记的各种激动剂和拮抗剂的分布以及新衍生物的体外结合亲和力进行了比较。一种心脏选择性阻滞剂阿普洛尔的放射性碘化衍生物显示出血清清除率低且无心脏选择性。另一种心脏选择性阻滞剂普拉洛尔的一种衍生物显示出有前景的心脏与血液比值(约为19)以及心脏选择性,心脏与肺的比值约为2。另外两种普拉洛尔类似物与普拉洛尔衍生物相比没有改善;由于这些衍生物亲脂性增加,血清清除率和心脏选择性降低。提示肺中β-肾上腺素能受体的解离常数与心脏与血液以及心脏与肺的值之间呈负相关。我们得出结论,极性在这些β-肾上腺素能受体衍生物的血清清除率和心脏选择性中起重要作用。